10 days ago
MAZE
AnalystsDebjit ChattopadhyayDebjit Chattopadhyay's Stock Forecasts
AnalystsDebjit Chattopadhyay
Sectors:
Industries:
Analyst Ranking
Top 9%
#468 out of 5216 analysts
Average Return
+16.31%
Win Rate
50%52 out of 103
Risk vs Reward
Poor
Good
Debjit Chattopadhyay's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | +399.86% | $10.37 | $51.84 | 2025-04-02 - 2026-03-12 | Strong Buy |
Maze Therapeutics IncMAZE | +328.57% | $10.57 | $45.30 | 2025-02-25 - 2026-02-24 | Strong Buy |
Pepgen IncPEPG | +315.54% | $1.48 | $6.15 | 2025-09-09 - 2026-03-12 | Strong Buy |
Jounce Therapeutics IncJNCE | +158.50% | $4.94 | $12.77 | 2020-03-02 - 2021-03-02 | Buy |
Sarepta Therapeutics IncSRPT | +134.33% | $55.25 | $129.47 | 2017-12-01 - 2018-11-30 | Buy |
Debjit Chattopadhyay Analyst Color
Get additional color on Debjit Chattopadhyay's coverage of popular stocks
17 days ago
KRYS
23 days ago
NAMS
23 days ago
PEPG
4 months ago
CNTA
6 months ago
QURE
6 months ago
IONS
6 months ago
MAZE
2 years ago
DYN
2 years ago
KRYS
Debjit Chattopadhyay's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | 4 | Strong Buy | $58.00 | +11.89% | Maintains | 10 days ago |
Krystal Biotech IncKRYS | 5 | Strong Buy | $284.00 | +13.01% | Maintains | 17 days ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $86.00 | +45.59% | Maintains | 17 days ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $45.00 | +50.91% | Maintains | 23 days ago |
Pepgen IncPEPG | 3 | Strong Buy | $7.00 | +13.82% | Maintains | 23 days ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $20.00 | +54.08% | Initiates Coverage On | a month ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $52.00 | +139.52% | Maintains | 2 months ago |
Rezolute IncRZLT | 3 | Strong Buy | $6.00 | +98.68% | Maintains | 3 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $39.00 | +47.84% | Maintains | 3 months ago |
Centessa Pharmaceuticals PLCCNTA | 7 | Strong Buy | $43.00 | +57.97% | Maintains | 4 months ago |
Sarepta Therapeutics IncSRPT | 7 | Strong Buy | $19.00 | +11.50% | Maintains | 4 months ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $30.00 | +352.49% | Initiates Coverage On | 5 months ago |
Uniqure NvQURE | 5 | Strong Buy | $95.00 | +460.80% | Maintains | 6 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Strong Buy | $92.00 | +27.18% | Maintains | 6 months ago |
Soleno Therapeutics IncSLNO | 5 | Strong Buy | $106.00 | +188.51% | Reiterates | 7 months ago |
Passage Bio IncPASG | 3 | Strong Buy | $10.00 | +23.46% | Maintains | 7 months ago |
Intellia Therapeutics IncNTLA | 3 | Strong Buy | $14.00 | +8.95% | Maintains | 7 months ago |
Vertex Pharmaceuticals IncVRTX | 6 | Strong Buy | $546.00 | +14.19% | Maintains | 7 months ago |
Dyne Therapeutics IncDYN | 4 | Strong Buy | $50.00 | +176.85% | Reiterates | 9 months ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $55.00 | +114.93% | Maintains | 10 months ago |
Prime Medicine IncPRME | 3 | Strong Buy | $18.00 | N/A | Reiterates | a year ago |
Benitec Biopharma IncBNTC | 2 | Strong Buy | $17.00 | N/A | Reiterates | a year ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Allogene Therapeutics IncALLO | 1 | Buy | $29.00 | N/A | Maintains | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 5 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $255.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 3 | Hold | $123.00 | N/A | Downgrades | 6 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Tectonic Therapeutic IncTECX | 3 | Hold | $156.00 | N/A | Downgrades | 6 years ago |
Zymeworks IncZYME | 1 | Buy | $60.00 | N/A | Reiterates | 6 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $10.00 | N/A | Reiterates | 6 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $20.00 | N/A | Maintains | 6 years ago |
Immunogen IncIMGN | 2 | Hold | $3.50 | N/A | Downgrades | 7 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $33.00 | N/A | Maintains | 7 years ago |
Global Blood Therapeutics IncGBT | 4 | Buy | $125.00 | N/A | Maintains | 8 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.